Precision oncology by Sameta Biomedical

DNA-Driven Analytics
for Precision Oncology.

OmixMe's personalized medical analysis identifies your unique genetic profile, empowering doctors to replace standard chemotherapy with targeted therapies that improve cancer survival rates and reduce side effects.

Standard oncology often relies on a "one-size-fits-all" playbook, but your tumour is unique.

4 Hidden Risks of Using Standard Statistics Over Molecular Biology for Cancer Treatment.

Standard therapy stopped working.

First-line chemotherapy fails for many patients with advanced cancer. You then wait for the next scan to confirm what your body already knows — and start over.

Nobody can tell you WHY.

Two patients with the same diagnosis can receive the same protocol — and the same protocol can fail for entirely different molecular reasons. Without reading your tumour's DNA, every decision is partly a guess.

You're losing time you don't have.

Trial-and-error treatment costs months per failed protocol. In advanced cancer, time is the one thing you cannot buy back.

Most clinical trials stay invisible to you.

The majority of trials require molecular data your hospital doesn't routinely generate. Without that data, you remain a generic candidate — never a verified molecular match.

Precision Oncology: 3 Layers of AI-Driven Evidence for Targeted Cancer Treatment.

We integrate deep DNA sequencing, liquid biopsy blood monitoring, and AI-driven clinical trial matching to provide your oncologist with a molecular GPS for highly targeted cancer care.

Multi-omics tumour profiling

We sequence cancer-relevant genes and analyse RNA expression so your doctor can see molecular signals that standard biopsies don't reveal.

Whole Genome Analysis

Sequencing and analysing an individual's entire DNA to identify genetic mutations, structural changes, and other genomic alterations associated with disease, including cancer.

AI-driven bioinformatics

Your molecular profile is matched against the global evidence base to help predict which therapies are most likely to work on your specific tumour — not on an average patient.

So how does it actually work?

The process is straightforward and physician-led:

  1. Patient consults their doctor
  2. Doctor arranges medical records and sample review
  3. OmixMe performs analysis
  4. Doctor receives the molecular report
  5. Doctor discusses next steps and treatment options with the patient

Precision Cancer Mapping: Stop Guessing and Start Targeted Therapy.

In ideal circumstances, the patient's physician will receive the completed molecular analysis within approximately 14–30 days after the tumour sample has been received and confirmed for processing.

Connect us with your doctor

Exactly what you receive.

No vague "insights." No 4-page summaries. Four concrete deliverables, in your hands within two weeks.

Molecular report

Plain-English summary up front. Full clinical-grade detail in the back — written so your oncologist can act on it on day one.

Targeted therapy options

We provide your oncologist with precise analysis of your tumour, which will help him set up the best possible therapy for a specific tumour in a particular patient.

Whole genome analysis

Sequenced from your tumour. DNA, RNA expression and ctDNA in one panel.

From sample to report

From sample arrival to your full report in 2 weeks – 1 month. Not 6 months. Not 2 months. Days.

Why it matters
20–40%

Standard chemotherapy

Objective response rate in the same molecularly defined disease.

50–70%

Matched targeted therapy

Across well-validated targets like EGFR, ALK, and BRAF.

Sources: JCO Precision Oncology (2021) · Therapeutic Advances in Medical Oncology (2022).

One coordinated workflow

Sample collection, sequencing, AI interpretation, written report, expert consultation, and direct dialogue with your oncologist. Whether your tumour sample is 30 mg, 500 mg, or just a 10 mL blood draw — the process is the same.

Get transparent pricing

Once we have consulted with your oncologist to understand your specific clinical needs, we will generate a customized quote based on their input. We will then send you the price no commitment required and no hidden costs. The whole package, nothing separately billed later.

Connect us with your doctor
OmixMe in one paragraph

A Simple, Stress-Free Process: From Testing to Your Targeted Treatment Plan.

We handle the logistics, the lab work, the interpretation, and the conversation with your oncologist. You and your family stay focused on what matters — your treatment and recovery.

  • Records received
  • Sample confirmed
  • Analysis completed
  • Report reviewed
  • Report delivered to physician

Why OmixMe is not "just another genetic test."

A standard lab returns variants. We return decisions your care team can act on.

OmixMe helps patients gain:

  • A deeper molecular understanding of their disease
  • More informed discussions about treatment options
  • Insight into potentially effective therapies
  • Awareness of clinical trial opportunities

This approach helps clarify the biological nature of the disease and supports more personalized care decisions.

Not sure yet? Simply connect us with your oncologist, and our experts will send them all the necessary information.

Connect us with your doctor

The Experts Behind Your Precision Care: Why Patients and Doctors Trust OmixMe.

OmixMe is powered by Sameta Biomedical, a world-class team of bioinformaticians, AI engineers, and molecular medicine experts with decades of experience in biotech and clinical research. To ensure the highest clinical accuracy, every personalized analysis is verified by an active oncology researcher, bridging the gap between advanced data science and life-saving cancer treatment.

Mgr. Miroslav Chovanec, PhD — Director of the Cancer Research Institute
Verified researcher

Mgr. Miroslav Chovanec, PhD

Director of the Cancer Research Institute at the Biomedical Research Center of the Slovak Academy of Sciences, public research institution.

Every OmixMe report is reviewed and validated by an active oncology researcher before it reaches you.

Honest about who this is, and isn't, for.

We'd rather lose a sale than enroll a patient OmixMe can't actually help. Read both columns.

OmixMe is for you if…

  • You or a loved one has been diagnosed with advanced or metastatic cancer (lung, breast, colorectal, pancreatic, melanoma, sarcoma, rare tumours).
  • First- or second-line standard therapy has stopped working — or your oncologist has flagged a high risk of recurrence.
  • You want to know whether targeted therapy or a clinical trial exists for your specific mutation, anywhere in the world.
  • You're an oncologist or institution managing complex cases and need molecular-level decision support.

OmixMe is NOT for you if…

  • You're looking for a hereditary risk test (BRCA screening, family planning) — that's a different service.
  • You expect a guaranteed cure. We don't sell hope. We sell the highest-resolution map of your tumour that current science can produce.
  • You're not ready to share your medical records or coordinate with your treating doctor — OmixMe only works as part of an active care team.

You don't need to be a scientist. Just ask your doctor this.

"I've heard about personalized medicine and biomarker testing by OmixMe. I'd like to analyze my tumor sample to see if there's a therapy targeting my specific molecular typos."

"I want the most advanced plan possible. Can we use personalized analytics to assess molecular data and personalize my cancer treatment?"

And if you'd rather we coordinate with your oncologist directly — that's exactly what we do.

Frequently asked questions.

If yours isn't here, ask us in the form below. We answer every email in person.

Your tumour has a code.
Don't wait until it's too late to read it.

Every week of standard trial-and-error is a week your tumour evolves. In a matter of days you could be holding a treatment plan written for your biology — not the average patient's.

Connect us with your doctor

We coordinate with your treating oncologist directly. No commitment required.

Connect us with your doctor.

Share a few details below and we'll reach out to your treating oncologist with everything they need to evaluate whether OmixMe is the right next step for your care.

  • Rapid Reporting

    An accelerated workflow so your doctor receives the report quickly.

  • Confidential & Secure

    Your medical data remains private and is never shared without your explicit consent.

  • Transparent, Fixed Pricing

    A comprehensive quote with no commitment and no hidden costs.

  • Doctor-first

    Every finding is reviewed with — and delivered to — your treating physician, who remains your primary medical contact.

All data are collected and processed in accordance with the General Data Protection Regulation (GDPR), ensuring compliance with applicable data protection and privacy laws.

Your information is treated confidentially and never shared without your explicit consent.